No open-access location is known for this record yet.
No open-access location is known for this record yet.
Purpose The purpose of this research paper is to benchmark the evolution of reported sustainability activity in the pharmaceutical sector, which has been recognized as a leading sector in industrial sustainability. Design/methodology/approach The authors examined recent published corporate sustainability activity reports for 11 pharmaceutical sector‐related companies and compared this to a similar earlier study. Findings Sustainability related activity has increased in breadth and depth, but activity is now being shifted toward corporate social responsibility, which is reflective of corporate need to satisfy public sentiment. Research limitations/implications The paper is formed on the basis of voluntarily reported activities and published documentation, therefore, it does contain a potential for bias and “greenwashing”; however, regardless of the impetus, the integration of sustainability is still evident. Practical implications The paper is of value to the practicioner and manager to benchmark the venues and activities reported for sustainability, in other words, what is the sector participating in and what is it reporting? Originality/value Benchmarking of corporate practice in a sustainability leadership sector provides a glimpse into the emerging standard of practice for industry.
Loading…
Stored only when both papers are in the corpus — 74 citations exist upstream.
Imported from OpenAlex (CC0) — nothing here is generated.